Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $80.10.
A number of research analysts have weighed in on HSIC shares. Barrington Research lifted their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research note on Thursday, January 30th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Jefferies Financial Group lifted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd.
Check Out Our Latest Research Report on Henry Schein
Insiders Place Their Bets
In other news, COO Michael S. Ettinger sold 12,240 shares of the business's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company's stock.
Institutional Investors Weigh In On Henry Schein
A number of institutional investors have recently modified their holdings of the business. Smartleaf Asset Management LLC boosted its position in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares during the period. CIBC Asset Management Inc lifted its position in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock worth $1,235,000 after purchasing an additional 169 shares during the period. Cromwell Holdings LLC lifted its position in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after purchasing an additional 170 shares during the period. Studio Investment Management LLC lifted its position in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock worth $341,000 after purchasing an additional 172 shares during the period. Finally, Metis Global Partners LLC lifted its position in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after purchasing an additional 187 shares during the period. Institutional investors own 96.62% of the company's stock.
Henry Schein Trading Down 1.1 %
Henry Schein stock traded down $0.85 during midday trading on Wednesday, hitting $79.00. 1,141,263 shares of the stock were exchanged, compared to its average volume of 1,474,978. The company has a fifty day simple moving average of $73.70 and a two-hundred day simple moving average of $71.78. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The stock has a market capitalization of $9.85 billion, a PE ratio of 32.51, a P/E/G ratio of 2.21 and a beta of 0.91. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the firm earned $1.32 EPS. Henry Schein's quarterly revenue was up .4% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein will post 4.76 EPS for the current fiscal year.
Henry Schein Company Profile
(
Get Free ReportHenry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.